![Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer | Bentham Science Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/ccdt/19/10/002.jpg)
Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer | Bentham Science
![Batman : Michael Keaton, Jack Nicholson, Kim Basinger, Robert Wuhl, Pat Hingle, Billy Dee Williams, Michael Gough, Jack Palance, Jerry Hall, Sam Hamm, Warren Skaaren, Tim Burton, Jon Peters, Peter Guber: Amazon.de: Batman : Michael Keaton, Jack Nicholson, Kim Basinger, Robert Wuhl, Pat Hingle, Billy Dee Williams, Michael Gough, Jack Palance, Jerry Hall, Sam Hamm, Warren Skaaren, Tim Burton, Jon Peters, Peter Guber: Amazon.de:](https://images-na.ssl-images-amazon.com/images/I/81EFbzVtWGL._RI_.jpg)
Batman : Michael Keaton, Jack Nicholson, Kim Basinger, Robert Wuhl, Pat Hingle, Billy Dee Williams, Michael Gough, Jack Palance, Jerry Hall, Sam Hamm, Warren Skaaren, Tim Burton, Jon Peters, Peter Guber: Amazon.de:
![Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes | Journal of Hematology & Oncology | Full Text Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01166-3/MediaObjects/13045_2021_1166_Fig1_HTML.png)
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes | Journal of Hematology & Oncology | Full Text
![PDF) Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: A subanalysis from a phase 3 trial (MPACT) PDF) Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: A subanalysis from a phase 3 trial (MPACT)](https://i1.rgstatic.net/publication/309344816_Efficacy_and_safety_profile_of_nab-paclitaxel_plus_gemcitabine_in_patients_with_metastatic_pancreatic_cancer_treated_to_disease_progression_A_subanalysis_from_a_phase_3_trial_MPACT/links/5fc212e6a6fdcc6cc6778d26/largepreview.png)